FindTrial
Sign In

Correlation of Xanthelasma with atherosclerosis, liver fat and fibrosis

Association of Xanthelasma with sub clinical atherosclerosis and hepatic fat/fibrosis. A prospective case control study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/054847
Enrollment
150
Registered
2023-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

National Diabetes Obesity and Cholesterol Foundation
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with T2DM 2.Age 25 to 60 years 3.BMI >25 kg/m² to >40 kg/m² 4.Gender- Both (Male & Female) 5.Mild, moderate and severe Xanthelasma (Photograph)

Exclusion criteria

Exclusion criteria: 1.Alcoholic abuse or other causes of liver dysfunction. 2.Severe end organ damage or chronic diseases: renal/hepatic failure, any malignancy, major systemic illness etc.

Design outcomes

Primary

MeasureTime frame
To correlate xanthelasma & its severity to pulse wave velocity & atherosclerosis as see in carotid doppler.Timepoint: 12 months—

Secondary

MeasureTime frame
To correlate xanthelasma to liver fat & fibrosis.Timepoint: 12 months—

Countries

India

Contacts

Public ContactDr Anoop Misra

Fortis CDOC Hospital

anoopmisra@gmail.com01149101222

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026